ID   CBX1_HUMAN              Reviewed;         185 AA.
AC   P83916; P23197;
DT   07-JUN-2004, integrated into UniProtKB/Swiss-Prot.
DT   07-JUN-2004, sequence version 1.
DT   10-MAY-2017, entry version 141.
DE   RecName: Full=Chromobox protein homolog 1;
DE   AltName: Full=HP1Hsbeta;
DE   AltName: Full=Heterochromatin protein 1 homolog beta;
DE            Short=HP1 beta;
DE   AltName: Full=Heterochromatin protein p25;
DE   AltName: Full=M31;
DE   AltName: Full=Modifier 1 protein;
DE   AltName: Full=p25beta;
GN   Name=CBX1; Synonyms=CBX;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND SUBCELLULAR LOCATION.
RC   TISSUE=Liver tumor;
RX   PubMed=9169582; DOI=10.1007/s004120050219;
RA   Furuta K., Chan E.K.L., Kiyosawa K., Reimer G., Luderschmidt C.,
RA   Tan E.M.;
RT   "Heterochromatin protein HP1Hsbeta (p25beta) and its localization with
RT   centromeres in mitosis.";
RL   Chromosoma 106:11-19(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, and Ovary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   PROTEIN SEQUENCE OF 8-25; 122-137; 140-150 AND 156-167, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Brain, Cajal-Retzius cell, and Fetal brain cortex;
RA   Lubec G., Afjehi-Sadat L., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [4]
RP   SUBCELLULAR LOCATION, AND LACK OF PHOSPHORYLATION.
RX   PubMed=10460410; DOI=10.1007/s004120050372;
RA   Minc E., Allory Y., Worman H.J., Courvalin J.-C., Buendia B.;
RT   "Localization and phosphorylation of HP1 proteins during the cell
RT   cycle in mammalian cells.";
RL   Chromosoma 108:220-234(1999).
RN   [5]
RP   INTERACTION WITH SUV39H1.
RX   PubMed=10202156; DOI=10.1093/emboj/18.7.1923;
RA   Aagaard L., Laible G., Selenko P., Schmid M., Dorn R., Schotta G.,
RA   Kuhfittig S., Wolf A., Lebersorger A., Singh P.B., Reuter G.,
RA   Jenuwein T.;
RT   "Functional mammalian homologues of the Drosophila PEV-modifier
RT   Su(var)3-9 encode centromere-associated proteins which complex with
RT   the heterochromatin component M31.";
RL   EMBO J. 18:1923-1938(1999).
RN   [6]
RP   INTERACTION WITH EMSY.
RX   PubMed=14651845; DOI=10.1016/S0092-8674(03)00930-9;
RA   Hughes-Davies L., Huntsman D., Ruas M., Fuks F., Bye J., Chin S.-F.,
RA   Milner J., Brown L.A., Hsu F., Gilks B., Nielsen T., Schulzer M.,
RA   Chia S., Ragaz J., Cahn A., Linger L., Ozdag H., Cattaneo E.,
RA   Jordanova E.S., Schuuring E., Yu D.S., Venkitaraman A., Ponder B.,
RA   Doherty A., Aparicio S., Bentley D., Theillet C., Ponting C.P.,
RA   Caldas C., Kouzarides T.;
RT   "EMSY links the BRCA2 pathway to sporadic breast and ovarian cancer.";
RL   Cell 115:523-535(2003).
RN   [7]
RP   MUTAGENESIS OF ILE-161.
RX   PubMed=15947784; DOI=10.1038/sj.embor.7400415;
RA   Ekblad C.M.S., Chavali G.B., Basu B.P., Freund S.M.V., Veprintsev D.,
RA   Hughes-Davies L., Kouzarides T., Doherty A.J., Itzhaki L.S.;
RT   "Binding of EMSY to HP1beta: implications for recruitment of HP1beta
RT   and BS69.";
RL   EMBO Rep. 6:675-680(2005).
RN   [8]
RP   INTERACTION WITH SETDB1.
RX   PubMed=15899859; DOI=10.1128/MCB.25.11.4552-4564.2005;
RA   Verschure P.J., van der Kraan I., de Leeuw W., van der Vlag J.,
RA   Carpenter A.E., Belmont A.S., van Driel R.;
RT   "In vivo HP1 targeting causes large-scale chromatin condensation and
RT   enhanced histone lysine methylation.";
RL   Mol. Cell. Biol. 25:4552-4564(2005).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=18318008; DOI=10.1002/pmic.200700884;
RA   Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,
RA   Zou H., Gu J.;
RT   "Large-scale phosphoproteome analysis of human liver tissue by
RT   enrichment and fractionation of phosphopeptides with strong anion
RT   exchange chromatography.";
RL   Proteomics 8:1346-1361(2008).
RN   [10]
RP   INTERACTION WITH CHAMP1 AND POGZ.
RX   PubMed=20850016; DOI=10.1016/j.cell.2010.08.020;
RA   Vermeulen M., Eberl H.C., Matarese F., Marks H., Denissov S.,
RA   Butter F., Lee K.K., Olsen J.V., Hyman A.A., Stunnenberg H.G.,
RA   Mann M.;
RT   "Quantitative interaction proteomics and genome-wide profiling of
RT   epigenetic histone marks and their readers.";
RL   Cell 142:967-980(2010).
RN   [11]
RP   INTERACTION WITH ASXL1.
RX   PubMed=19880879; DOI=10.1074/jbc.M109.065862;
RA   Lee S.W., Cho Y.S., Na J.M., Park U.H., Kang M., Kim E.J., Um S.J.;
RT   "ASXL1 represses retinoic acid receptor-mediated transcription through
RT   associating with HP1 and LSD1.";
RL   J. Biol. Chem. 285:18-29(2010).
RN   [12]
RP   INTERACTION WITH POGZ.
RX   PubMed=20562864; DOI=10.1038/ncb2075;
RA   Nozawa R.S., Nagao K., Masuda H.T., Iwasaki O., Hirota T., Nozaki N.,
RA   Kimura H., Obuse C.;
RT   "Human POGZ modulates dissociation of HP1alpha from mitotic chromosome
RT   arms through Aurora B activation.";
RL   Nat. Cell Biol. 12:719-727(2010).
RN   [13]
RP   UBIQUITINATION.
RX   PubMed=20498703; DOI=10.1371/journal.pone.0010620;
RA   Chaturvedi P., Parnaik V.K.;
RT   "Lamin A rod domain mutants target heterochromatin protein 1alpha and
RT   beta for proteasomal degradation by activation of F-box protein,
RT   FBXW10.";
RL   PLoS ONE 5:E10620-E10620(2010).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-89, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-89; SER-91 AND SER-175,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-89, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [19]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-9, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25755297; DOI=10.1074/mcp.O114.044792;
RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurdsson J.O., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "System-wide analysis of SUMOylation dynamics in response to
RT   replication stress reveals novel small ubiquitin-like modified target
RT   proteins and acceptor lysines relevant for genome stability.";
RL   Mol. Cell. Proteomics 14:1419-1434(2015).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 104-175 IN COMPLEX WITH EMSY.
RX   PubMed=16615912; DOI=10.1016/j.str.2006.01.007;
RA   Huang Y., Myers M.P., Xu R.-M.;
RT   "Crystal structure of the HP1-EMSY complex reveals an unusual mode of
RT   HP1 binding.";
RL   Structure 14:703-712(2006).
RN   [21]
RP   X-RAY CRYSTALLOGRAPHY (1.93 ANGSTROMS) OF 108-185 IN COMPLEX WITH
RP   SGO1, AND INTERACTION WITH INCENP.
RX   PubMed=21346195; DOI=10.1091/mbc.E11-01-0009;
RA   Kang J., Chaudhary J., Dong H., Kim S., Brautigam C.A., Yu H.;
RT   "Mitotic centromeric targeting of HP1 and its binding to Sgo1 are
RT   dispensable for sister-chromatid cohesion in human cells.";
RL   Mol. Biol. Cell 22:1181-1190(2011).
CC   -!- FUNCTION: Component of heterochromatin. Recognizes and binds
CC       histone H3 tails methylated at 'Lys-9', leading to epigenetic
CC       repression. Interaction with lamin B receptor (LBR) can contribute
CC       to the association of the heterochromatin with the inner nuclear
CC       membrane.
CC   -!- SUBUNIT: Homodimer. Interacts directly with CHAF1A, EMSY, LBR,
CC       TIF1/TIF1A and TRIM28/TIF1B PXVXL motif via the chromoshadow
CC       domain. Interacts directly with histone H3 methylated at 'Lys-9'
CC       via the chromo domain. Interacts with SUV39H1 and SETDB1, KMT5B
CC       and KMT5C. Interacts with PRDM6. Interacts with POGZ. Interacts
CC       with CHAMP1. Interacts with ASXL1. Interacts with INCENP.
CC       Interacts with SGO1; the CBX1 homodimer binds to one molecule of
CC       SGO1. {ECO:0000269|PubMed:10202156, ECO:0000269|PubMed:14651845,
CC       ECO:0000269|PubMed:15899859, ECO:0000269|PubMed:16615912,
CC       ECO:0000269|PubMed:19880879, ECO:0000269|PubMed:20562864,
CC       ECO:0000269|PubMed:20850016, ECO:0000269|PubMed:21346195}.
CC   -!- INTERACTION:
CC       Q9H2P0:ADNP; NbExp=3; IntAct=EBI-78129, EBI-1764854;
CC       Q6IQ32:ADNP2; NbExp=3; IntAct=EBI-78129, EBI-2838654;
CC       Q13111:CHAF1A; NbExp=3; IntAct=EBI-78129, EBI-1020839;
CC       P68431:HIST1H3D; NbExp=9; IntAct=EBI-78129, EBI-79722;
CC       P10588:NR2F6; NbExp=2; IntAct=EBI-78129, EBI-2681496;
CC       Q5FBB7:SGO1; NbExp=2; IntAct=EBI-78129, EBI-989069;
CC       O43463:SUV39H1; NbExp=3; IntAct=EBI-78129, EBI-349968;
CC       Q8ND82:ZNF280C; NbExp=3; IntAct=EBI-78129, EBI-8831272;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10460410,
CC       ECO:0000269|PubMed:9169582}. Note=Unassociated with chromosomes
CC       during mitosis.
CC   -!- TISSUE SPECIFICITY: Expressed in all adult and embryonic tissues.
CC   -!- PTM: Not phosphorylated.
CC   -!- PTM: Ubiquitinated. {ECO:0000269|PubMed:20498703}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Heterochromatin protein 1
CC       entry;
CC       URL="https://en.wikipedia.org/wiki/Heterochromatin_Protein_1";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U35451; AAB81548.1; -; mRNA.
DR   EMBL; BC002609; AAH02609.1; -; mRNA.
DR   EMBL; BC021302; AAH21302.1; -; mRNA.
DR   CCDS; CCDS11525.1; -.
DR   PIR; G02080; G02080.
DR   RefSeq; NP_001120700.1; NM_001127228.1.
DR   RefSeq; NP_006798.1; NM_006807.4.
DR   UniGene; Hs.77254; -.
DR   PDB; 2FMM; X-ray; 1.80 A; A/B/C/D=104-175.
DR   PDB; 3F2U; X-ray; 1.80 A; A=20-73.
DR   PDB; 3Q6S; X-ray; 1.93 A; A/B/C/D=108-185.
DR   PDB; 5T1G; X-ray; 1.90 A; A=108-185.
DR   PDBsum; 2FMM; -.
DR   PDBsum; 3F2U; -.
DR   PDBsum; 3Q6S; -.
DR   PDBsum; 5T1G; -.
DR   ProteinModelPortal; P83916; -.
DR   SMR; P83916; -.
DR   BioGrid; 116151; 72.
DR   DIP; DIP-28135N; -.
DR   IntAct; P83916; 108.
DR   MINT; MINT-1378005; -.
DR   STRING; 9606.ENSP00000225603; -.
DR   BindingDB; P83916; -.
DR   ChEMBL; CHEMBL1741193; -.
DR   iPTMnet; P83916; -.
DR   PhosphoSitePlus; P83916; -.
DR   SwissPalm; P83916; -.
DR   BioMuta; CBX1; -.
DR   DMDM; 48428808; -.
DR   EPD; P83916; -.
DR   PaxDb; P83916; -.
DR   PeptideAtlas; P83916; -.
DR   PRIDE; P83916; -.
DR   TopDownProteomics; P83916; -.
DR   DNASU; 10951; -.
DR   Ensembl; ENST00000225603; ENSP00000225603; ENSG00000108468.
DR   Ensembl; ENST00000393408; ENSP00000377060; ENSG00000108468.
DR   GeneID; 10951; -.
DR   KEGG; hsa:10951; -.
DR   CTD; 10951; -.
DR   DisGeNET; 10951; -.
DR   GeneCards; CBX1; -.
DR   HGNC; HGNC:1551; CBX1.
DR   HPA; CAB012265; -.
DR   MIM; 604511; gene.
DR   neXtProt; NX_P83916; -.
DR   OpenTargets; ENSG00000108468; -.
DR   PharmGKB; PA26126; -.
DR   eggNOG; ENOG410KDV3; Eukaryota.
DR   eggNOG; ENOG4111H4A; LUCA.
DR   GeneTree; ENSGT00510000046310; -.
DR   HOGENOM; HOG000220852; -.
DR   HOVERGEN; HBG000400; -.
DR   InParanoid; P83916; -.
DR   KO; K11585; -.
DR   OMA; WKGTDDA; -.
DR   OrthoDB; EOG091G0RBS; -.
DR   PhylomeDB; P83916; -.
DR   TreeFam; TF350503; -.
DR   SIGNOR; P83916; -.
DR   EvolutionaryTrace; P83916; -.
DR   GeneWiki; CBX1; -.
DR   GenomeRNAi; 10951; -.
DR   PRO; PR:P83916; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000108468; -.
DR   CleanEx; HS_CBX1; -.
DR   ExpressionAtlas; P83916; baseline and differential.
DR   Genevisible; P83916; HS.
DR   GO; GO:0000785; C:chromatin; IDA:UniProtKB.
DR   GO; GO:0010369; C:chromocenter; IEA:Ensembl.
DR   GO; GO:0000775; C:chromosome, centromeric region; IDA:UniProtKB.
DR   GO; GO:0001939; C:female pronucleus; IEA:Ensembl.
DR   GO; GO:0001940; C:male pronucleus; IEA:Ensembl.
DR   GO; GO:0000784; C:nuclear chromosome, telomeric region; IDA:BHF-UCL.
DR   GO; GO:0005720; C:nuclear heterochromatin; TAS:ProtInc.
DR   GO; GO:0005654; C:nucleoplasm; TAS:ProtInc.
DR   GO; GO:0005721; C:pericentric heterochromatin; IEA:Ensembl.
DR   GO; GO:0005819; C:spindle; IDA:UniProtKB.
DR   GO; GO:0003682; F:chromatin binding; TAS:ProtInc.
DR   GO; GO:0019899; F:enzyme binding; IPI:UniProtKB.
DR   GO; GO:1990226; F:histone methyltransferase binding; IPI:BHF-UCL.
DR   GO; GO:0042803; F:protein homodimerization activity; IEA:Ensembl.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:Ensembl.
DR   InterPro; IPR000953; Chromo/chromo_shadow_dom.
DR   InterPro; IPR017984; Chromo_dom_subgr.
DR   InterPro; IPR023780; Chromo_domain.
DR   InterPro; IPR008251; Chromo_shadow_dom.
DR   InterPro; IPR016197; Chromodomain-like.
DR   InterPro; IPR023779; Chromodomain_CS.
DR   Pfam; PF00385; Chromo; 1.
DR   Pfam; PF01393; Chromo_shadow; 1.
DR   PRINTS; PR00504; CHROMODOMAIN.
DR   SMART; SM00298; CHROMO; 2.
DR   SMART; SM00300; ChSh; 1.
DR   SUPFAM; SSF54160; SSF54160; 2.
DR   PROSITE; PS00598; CHROMO_1; 1.
DR   PROSITE; PS50013; CHROMO_2; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Direct protein sequencing;
KW   Isopeptide bond; Nucleus; Phosphoprotein; Reference proteome; Repeat;
KW   Ubl conjugation.
FT   CHAIN         1    185       Chromobox protein homolog 1.
FT                                /FTId=PRO_0000080199.
FT   DOMAIN       21     79       Chromo 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00053}.
FT   DOMAIN      117    175       Chromo 2; shadow subtype.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00053}.
FT   BINDING      21     21       Histone H3K9me2. {ECO:0000250}.
FT   BINDING      23     23       Histone H3A7. {ECO:0000250}.
FT   BINDING      40     40       Histone H3A7. {ECO:0000250}.
FT   BINDING      42     42       Histone H3A7. {ECO:0000250}.
FT   BINDING      42     42       Histone H3K9me2. {ECO:0000250}.
FT   BINDING      45     45       Histone H3K9me2. {ECO:0000250}.
FT   BINDING      58     58       Histone H3A7. {ECO:0000250}.
FT   BINDING      60     60       Histone H3A7. {ECO:0000250}.
FT   BINDING     125    125       PxVxL motif. {ECO:0000250}.
FT   BINDING     126    126       PxVxL motif. {ECO:0000250}.
FT   BINDING     135    135       PxVxL motif. {ECO:0000250}.
FT   BINDING     146    146       PxVxL motif. {ECO:0000250}.
FT   BINDING     163    163       PxVxL motif. {ECO:0000250}.
FT   BINDING     167    167       PxVxL motif. {ECO:0000250}.
FT   BINDING     168    168       PxVxL motif. {ECO:0000250}.
FT   BINDING     170    170       PxVxL motif. {ECO:0000250}.
FT   MOD_RES      89     89       Phosphoserine.
FT                                {ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES      91     91       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   MOD_RES     175    175       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   CROSSLNK      9      9       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO2).
FT                                {ECO:0000244|PubMed:25755297}.
FT   MUTAGEN     161    161       I->E: Abolishes homodimer formation and
FT                                binding to EMSY.
FT                                {ECO:0000269|PubMed:15947784}.
FT   STRAND       23     32       {ECO:0000244|PDB:3F2U}.
FT   STRAND       35     42       {ECO:0000244|PDB:3F2U}.
FT   HELIX        47     49       {ECO:0000244|PDB:3F2U}.
FT   STRAND       51     54       {ECO:0000244|PDB:3F2U}.
FT   HELIX        55     57       {ECO:0000244|PDB:3F2U}.
FT   HELIX        61     68       {ECO:0000244|PDB:3F2U}.
FT   HELIX       112    115       {ECO:0000244|PDB:2FMM}.
FT   STRAND      119    128       {ECO:0000244|PDB:2FMM}.
FT   STRAND      131    138       {ECO:0000244|PDB:2FMM}.
FT   STRAND      145    148       {ECO:0000244|PDB:2FMM}.
FT   HELIX       149    155       {ECO:0000244|PDB:2FMM}.
FT   HELIX       157    165       {ECO:0000244|PDB:2FMM}.
FT   STRAND      168    172       {ECO:0000244|PDB:2FMM}.
SQ   SEQUENCE   185 AA;  21418 MW;  BE687AF9C66E48E3 CRC64;
     MGKKQNKKKV EEVLEEEEEE YVVEKVLDRR VVKGKVEYLL KWKGFSDEDN TWEPEENLDC
     PDLIAEFLQS QKTAHETDKS EGGKRKADSD SEDKGEESKP KKKKEESEKP RGFARGLEPE
     RIIGATDSSG ELMFLMKWKN SDEADLVPAK EANVKCPQVV ISFYEERLTW HSYPSEDDDK
     KDDKN
//
